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Increased Expression of Adenosine Triphosphate-Sensitive
K Channels in Mitral Dysfunction
Mechanically Stimulated Transcription
and Hypoxia-Induced Protein Stability?
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Objectives The aim of this study was to test whether adenosine triphosphate-sensitive K (KATP) channel expression re-
lates to mechanical and hypoxic stress within the left human heart.
Background The KATP channels play a vital role in preserving the metabolic integrity of the stressed heart. However, the
mechanisms that govern the expression of their subunits (e.g., potassium inward rectifier [Kir] 6.2) in adult
pathologies are mostly unknown.
Methods We collected biopsies from the 4 cardiac chambers and 50 clinical parameters from 30 surgical patients with
severe mitral dysfunction. Proteins and messenger ribonucleic acids (mRNAs) of KATP pore subunits and
mRNAs of their known transcriptional regulators (forkhead box [FOX] F2, FOXO1, FOXO3, and hypoxia inducible
factor [HIF]-1) were measured respectively by Western blotting, immunohistochemistry, and quantitative real-
time polymerase chain reaction, and submitted to statistical analysis.
Results In all heart chambers, Kir6.2 mRNA correlated with HIF-1 mRNA. Neither Kir6.1 nor Kir6.2 proteins positively
correlated with their respective mRNAs. The HIF-1 mRNA related in the left ventricle to aortic pressure, in the
left atrium to left atrial pressure, and in all heart chambers to a decreased Kir6.2 protein/mRNA ratio. Interest-
ingly, in the left heart, Kir6.2 protein and its immunohistochemical detection in myocytes were maximal at low
venous PO2. In the left ventricle, the Kir6.2 protein/mRNA ratio was also significantly higher at low venous PO2,
suggesting that tissue hypoxia might stabilize the Kir6.2 protein.
Conclusions Results suggest that post-transcriptional events determine Kir6.2 protein expression in the left ventricle of patients
with severe mitral dysfunction and low venous PO2. Mechanical stress mainly affects transcription of HIF-1 and
Kir6.2. This study implies that new therapies could aim at the proteasome for stabilizing the left ventricular Kir6.2
protein. (J Am Coll Cardiol 2012;59:390–6) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.077Mitral regurgitation (MR) is a common disease and in-
creases in frequency with age: 19% by a mean age of 54 years
in the Framingham cohort (1), and exceeding 80% by 80
years of age (2). Nearly 20% to 30% of patients experience
MR after myocardial infarction (3). Structural changes
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they have no relationships relevant to the contents of this paper to disclose. Drs.
Raeis-Dauvé and Philip-Couderc are both primary authors.Manuscript received June 6, 2011; revised manuscript received July 26, 2011,
accepted August 17, 2011.involving left ventricular geometry, the mitral annulus, and
the valvular/subvalvular apparatus often appear with MR.
They result in clinically significant valve incompetence (3),
and malfunction of the valve itself due to tethering. When
the insufficiency becomes more severe, surgical correction is
often required, but not all patients can tolerate the surgical
procedure (4). Consequently, a better understanding of
cardiac adaptation to MR could lead to therapies for
delaying the surgical intervention.
See page 397
The adenosine triphosphate-sensitive potassium (KATP)
channels are beneficial in the adaptation to cardiac stress.
They partly mediate ischemic pre-conditioning in human
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mutations of the regulatory sulfonyl urea receptor (SUR) 2A
subunit confer susceptibility to dilated cardiomyopathy (7)
and adrenergic atrial fibrillation (8). The KATP channels
play a vital role during vigorous exercise in mice and men as
demonstrated, for example, in a study on transgenic mice
with knockout of the pore-forming high conductance KATP-
channel subunit potassium inward rectifier (Kir) 6.2, or over-
expression of dominant negative Kir6.1 (9,10). These mice only
tolerate one-half of the workload compared with wild-type
mice, and one-half of them die. In children who have
congenital heart disease (11), venous hypoxemia was an under-
lying factor for over-expression of forkhead box (FOX) O1,
Kir6.1, and SUR2. In the infarct border zone of the rat left
ventricle (LV), FOXO1 is linked to increased Kir6.1 ex-
pression (12), whereas in rat atrial myocytes, hypoxia-inducible
factor (HIF)-1 is causally involved in hypoxia-induced
ctivation of FOXO1 (11).
Several important questions remain unanswered. Mechani-
al stress accompanies different cardiac pathologies, but its role
n Kir6.1 and Kir6.2 expression is still unknown. The signaling
athway for Kir6.2 expression is not established, and intrigu-
ngly, during venous hypoxemia, no correlation exists between
ir6.2 mRNA and Kir6.2 protein (11). Moreover, the signal-
ng pathways may differ between right atrial Kir6.1 in children
ith congenital heart disease, and left ventricular Kir6.2 in
dults with MR. In the present study involving MR patients,
e focused on identifying the most important, potential
eterminants of KATP-channel pore expression. We related
iochemical measurements on cardiac biopsies to blood pres-
ures and sizes of the cardiac chambers, and to blood gases and
lood chemistry. The results suggest that mechanical stress
ctivates transcription of Kir6.2 mRNA, whereas tissue hyp-
xia likely operates through post-transcriptional mechanisms
y inhibiting Kir6.2 protein degradation.
ethods
xperimental approach. We conducted this study on a
urgical patient population with MR because specific pro-
ein and mRNA contents of cardiac biopsies can be related
o a large array of clinical data. This approach also has the
dvantage of finding a broad range of values of the clinical
arameters within a relatively homogenous patient popula-
ion. Highly significant correlations emerging from the
tatistical analysis thus point to novel potential determinants
f KATP subunit expression. Although Kir6 knockout mice
ith various degrees of MR would be an interesting model,
ice models of MR do not yet exist. A rat model of MR has
een established (13), but as in mice, fewer parameters are
easurable when compared to human studies.
atient population. This study reports results from 30
dults (22 women, 8 men), ages 60 to 79 years (and 1 at age
5 years). The patients had severe mitral dysfunction
ccompanied by mild to moderate tricuspid valve disease,
ith indications for mitral and tricuspid valve repair. They aere prospectively enrolled be-
ween January 2007 and June
009. All patients gave their in-
ormed written consent to have
yocardial biopsies performed
nd specimens used for experi-
entation. This study was ap-
roved by the local institutional eth-
cs committee (MU 301390-07).
issue samples. All myocardial
iopsies were performed during
ardiopulmonary bypass, imme-
iately after cardioplegic cardiac
rrest. A Scholten Bioptome
Scholten Surgical Instruments,
odi, California) was used for
he left and right ventricle spec-
mens (3-mm-thick samples
eighing between 10 mg and 25
g) obtained close to the base of
he papillary muscles. A strip 4
m in length of left and right atrial free walls was excised
t the atriotomy level.
rotocol. At the beginning of anesthesia, artificial respiration
as switched during 5 min from 50% to 21% oxygen. After
his equilibration—designed to reach the blood gas levels
resumably prevailing before anesthesia—venous and arterial
lood samples (0.5 ml) were withdrawn for immediate analysis
f pH, blood gases, and plasma concentrations of hemoglobin,
lucose, lactate, Ca, Na, K, Cl, and calculated bicar-
onate (Online Table 1). Blood pressures were measured in all
ardiac chambers and aorta. Part of the biopsies (see the
receding text) was collected in liquid nitrogen for protein and
NA extractions, and part was washed in phosphate-buffered
aline and fixed in 3% paraformaldehyde for histology.
ata. We collected data on a total of 50 parameters such as
ge, sex, echocardiographically determined size and thickness
f all cardiac chambers (obtained during pre-operative consul-
ation), and parameters cited previously (Online Table 1).
omparison of the effect of MR on hemodynamic parameters
ith normal values (14) indicates an increase of right and left
trial pressures (Online Table 1), in accordance with reported
alues (15–17).
estern blot tests. Pieces of right atrium (RA), left atrium
LA), right ventricle (RV), and LV tissues were placed in
omogenization/lysis buffer (25 mM Tris, 150 mM NaCl, 5
M ethylenediaminetetraacetic acid [1% vol/vol], TritonX-
00, pH 7.4, supplemented with protease inhibitor cocktail
Roche, Basel, Switzerland]), and was further homogenized,
entrifuged, and processed as described (12). Supernatants
ere loaded on a polyacrylamide-sodium dodecyl sulfate gel
10%), and blotted (12). Loading controls were performed
y red Ponceau staining. Reference samples were co-applied
n all gels to allow for intergel comparisons of Kir6 signals.
olyclonal goat anti-Kir6.1 antibody (R14 SC-11224) and
Abbreviations
and Acronyms
FOX  forkhead box
HIF  hypoxia-inducible
factor
KATP  adenosine
triphosphate-sensitive
potassium
Kir  potassium inward
rectifier
LA  left atrium
LV  left ventricle
MR  mitral regurgitation
mRNA  messenger
ribonucleic acid
RA  right atrium
RV  right ventricle
SUR  sulfonyl urea
receptornti-Kir6.2 (G16 SC-11228,) were diluted 1/400 and
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described (11). Quantification of the detected proteins was
performed by scanning and with MetaMorph software
(Universal Imaging, Downingtown, Pennsylvania).
RNA extraction, reverse transcription, and real-time
PCR. After RNA extraction and reverse transcription,
real-time PCR was performed with specific primers for
human KATP channel subunits Kir6.1, Kir6.2, SUR2A,
SUR2B, and transcription factors FOXO1, FOXO3,
FOXF2, and HIF-1. The primers were designed by
rimer Express software, version 2.0 (Applied Biosystems,
oster City, California), and synthesized by Mycrosynth
Balgach, Germany) (Online Table 2), as described (12).
tandard curves were established with a mix of all samples,
nd values normalized by hypoxanthine phosphoribosyl trans-
erase mRNA, which was chosen as the representative normal-
zation gene, as in previous human studies (11).
istology and immunohistochemistry. After fixation, tis-
ues were embedded in paraffin, and 5-m-thick sections were
ut and fixed on glass slides. Representative sections from each
ample were stained with hematoxylin and eosin for light
icroscopy. Immunohistochemical studies were carried out
sing a rabbit polyclonal antibody recognizing Kir6.2
Ab79171, Abcam, Cambridge, England) that was biotinyl-
ted using EZ-Link Biotinylation Kits (Thermo Fisher Sci-
ntific, Rockford, Illinois) as described (18). Immunoreactivity
as intensified by pressure cooker treatments for 5 min in
itrate buffer 10 mM, pH 6.0. To quench endogenous perox-
dase, slides were incubated with methanol containing 0.5%
ydrogen peroxide for 10 min. Sections were then incubated
ith anti-Kir6.2 (1/100) for 1 h, followed by monitoring with
he EnVision Kit (Dako, Glostrup, Denmark) with a high-
ensitivity alkaline-phosphatase-based second-generation visu-
lization. This treatment contains 3 steps interspersed with
insing in wash buffer: 30 min incubation with the Linker
olution, 30 min with the Enhancer solution, and 8 min with
he substrate added permanent red chromogen. Slides were
ounterstained with Hemalun and mounted in Eukitt (Kin-
ler, Freiburg, Germany).
mage analysis. For quantitative immunohistochemistry,
ets of images were acquired with a high-sensitivity camera
f a Mirax system (Carl Zeiss, Jena, Germany) using a
lan-Apochromat 20x/0.8 objective. In the scanning pro-
ess, the preview camera captured an overview of the whole
ample, and the software determined the scanning areas
ontaining the tissue areas. The unstained portion of the
pecimen automatically discriminated the immunostaining.
ixty sections and their negative controls were scanned and
tudied with MetaMorph software (Universal Imaging).
ixels were selected according to hue (dominant color tone),
ightness (color intensity), and saturation (color purity)
omponents (19). The negative control, in which only the
econd antibody was applied, was used to determine the
hreshold of positive staining above the background. Car-
iomyocytes, connective tissue, adipose tissue, and layers of
essels were manually circumscribed using MetaMorph moftware. Two calculations were performed: the ratio of the
um of the Kir6.2-positive areas of all types relative to the
otal area; and the percentage of the average integrated
ntensity of each region (cell type) relative to the integrated
ntensity of all regions.
tatistical analysis. Data are presented as mean  SEM,
ith “n” representing the number of patients. Mean values
btained were compared by the unpaired analysis of variance
est with a Tukey method for post-hoc comparisons. Pa-
ameters and levels of proteins and mRNAs were classed by
ank. Linear and second-degree polynomial correlations
ere performed on ranks with SPSS software (Chicago,
llinois) and/or Origin 6.0 software (OriginLab Corp.,
orthampton, Massachusetts). To minimize type-1 er-
ors (false positives) due to multiple tests, we mainly
onsidered pre-planned correlations in data interpreta-
ion. Such correlations involve the oxygen levels, param-
ters related to mechanical stress, and transcription
actors FOX and HIF-1. Figures 1, 2, 3, 4, and 5
display color-coded ranges of p levels; Online Figures 1
through 6 indicate exact p, N, and R. We do not show
non–pre-planned correlations, such as those involving
serum levels of glucose and electrolyte. There were no
sex-specific differences in outcome.
Results
Expression of left heart Kir6.2 protein depends on venous
PO2 but not Kir6.2 mRNA. Quantification by Western
blot of LV and LA Kir6.2 protein indicates that the high
expression correlates with low venous PO2 (Fig. 1). Because
tissue extracts contain not only cardiomyocytes but also
blood vessels, connective tissue, and adipocytes, tissue sec-
tions were immunostained for Kir6.2 by a sensitive tech-
nique (Fig. 2, Online Fig. 1). The morphometric analysis
indicates that most immunoreactive Kir6.2 is contained in
cardiomyocytes. Morphometry of tissue areas with Kir6.2
containing myocytes from LV and LA from 15 patients
shows a strong negative correlation of cardiomyocyte Kir6.2
staining with increasing venous PO2 (p  0.01, R 
0.544), indicating that the Western blots mirror the
Kir6.2 content of cardiomyocytes. The adipocyte content of
LA and LV is negligible, and the minor amount of Kir6.2
staining in connective tissue or blood vessel walls does not
correlate with decreasing venous PO2 (p  0.6).
A statistical analysis of left heart mRNAs and proteins
(Fig. 3, Online Fig. 2) shows that Kir6.2 mRNA bears no
signification correlation with venous PO2. The Kir6.2
rotein does not depend on arterial PO2, and the Kir6.1
rotein correlates with neither arterial nor venous PO2. In
he right heart, neither Kir6.1 nor Kir6.2 protein correlates
ith arterial or venous PO2 (Online Fig. 3).
Kir6.2 mRNA relates to HIF-1 mRNA expression. In
ll heart chambers, Kir6.2 mRNA strongly associates with
IF-1 mRNA (Fig. 3, Online Fig. 3). The SUR2B
RNA expression also strongly and positively associates
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January 24, 2012:390–6 KATP-Channel Expression in Mitral Dysfunctionwith HIF-1 mRNA (p  0.01) (Online Fig. 4). In
ddition, both left heart Kir6.1 and Kir6.2 mRNA correlate
ith one of the FOXOs. Strikingly, HIF-1 mRNA does
ot correlate at all with venous or arterial PO2, raising the
question of whether other clinical parameters might be
underlying factors for HIF-1 mRNA expression.
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Figure 1 Expression of Kir6.2 Protein in Left Heart at Different
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labeling above threshold were evenly stained using MetaMorph software. The pair
the increased staining at low PO .2Expression of LV HIF-1 and Kir6.2 mRNA relates to
echanical and echocardiographic parameters. Left ven-
ricular HIF-1 mRNA expression significantly associates
ith systolic aortic pressure and size of the LV, while LV
ir6.2 mRNA correlates with both systolic and diastolic aortic
ressure (Fig. 4, Online Fig. 5). The LA HIF-1 expression
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KATP-Channel Expression in Mitral Dysfunction January 24, 2012:390–6correlates with LA wedge pressure. In LA, however, Kir6.2
mRNA inversely correlates with LA cross-section and systolic
ventricular pressure. In striking contrast, the right heart
HIF-1 and Kir6 mRNA expressions are barely affected by
mechanical or echocardiographic parameters, but there are
prominent associations between these parameters and RA
FOXO mRNA and Kir6 proteins (Online Fig. 6).
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Figure 3 Relationships Between Blood Gases, mRNAs, and Pro
All values for left heart parameters and variables were ranked, and linear or quadr
coded (Online Fig. 2 lists p, N, and R). Quadratic relationships are marked by eith
venous PO2 dependence of potassium inward rectifier (Kir) 6.2 protein, lack of cor
patterns for LV and LA. The same analysis was applied to RV and RA (Online Fig.
head box; HIF  hypoxia-inducible factor; other abbreviations as in Figure 1.
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Figure 4 Relationships Between Mechanical and Echocardiogra
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as described in legend to Figure 3 (Online Fig. 5 lists p, N, and R). Note pressure
cleic acids (mRNAs) expression, but more distinct patterns between LV and LA tha
pressure; D  diameter; LAP  left atrial pressure; LVP  left ventricular pressure
viations as in Figures 1 and 3.Kir6.2 protein/mRNA ratios relate to venous PO2 and
IF-1. The ratio of Kir6.2 protein/Kir6.2 mRNA
is of interest to quantify the dissociation between mRNA
and protein. Indeed, the LV ratio for Kir6.2 significantly
increases at low venous PO2 (p  0.024, R  0.441, n 
6). As Kir6.2 mRNA is unchanged at low venous PO2
(Fig. 3), this increased ratio indicates an increased protein
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January 24, 2012:390–6 KATP-Channel Expression in Mitral Dysfunctionaccumulation. Conversely, the decreased ratio observed with
increased HIF-1 and Kir6.2 mRNA expression (Fig. 3)
ndicates that LV Kir6.2 protein does not change signifi-
antly with changes in HIF-1 mRNA.
Discussion
Increased KATP channel expression is of vital importance
during cardiac stress (5,6,9,10), but the mechanisms for this
expression are mostly unknown. This is the first study to
focus on the expression of KATP channel pore subunits and
relevant transcription factors within the 4 chambers of the
human heart, exposed, due to MR, to considerable mechan-
ical and hypoxic solicitations. The latter were sufficiently
severe to lead to surgical valve repair in the 30 patients of
this study.
Salient features of LV Kir6.2 expression. The main re-
sults on LV suggest an interesting dual, transcriptional and
post-translational regulation of Kir6.2 expression (Fig. 5).
The Kir6.2 protein expression appears to be dictated by
tissue hypoxia, independently of Kir6.2 mRNA expression.
The hypoxia results from low cardiac output (20) and is
revealed by a low venous PO2. Mechanical factors, in
contrast, determine the Kir6.2 mRNA expression but do
not directly affect Kir6.2 protein. The HIF-1 is a candi-
date mediator of increased Kir6.2 gene transcription in
response to mechanical stress. Bioinformatics indeed indi-
cates a binding site for HIF-1 on the Kir6.2 gene
promoter (but not on the Kir6.1 gene; results not shown).
The mechanism for increased LV Kir6.2 protein expres-
sion, due to hypoxic stress, most likely results from hypoxic
inhibition of the proteasomal degradation pathway of Kir6.2
(21–23). Alternatively, hypoxia, although usually an inhib-
itor of protein translation, may increase Kir6.2 translation,
as shown for vascular endothelial growth factor (24). How-
ever, no studies have yet been performed for Kir6.2 trans-
lation efficiency. In addition to increased protein stability of
Kir6.2 in hypoxia, repression of transcription by excess
protein (25) might explain the striking dissociation of
Mechanical
stress HIF-1α mRNA
Kir6.2 mRNA
Hypoxic
stress
Kir6.2 proteinKir6.2 gene
Figure 5 Left Ventricular Kir6.2 in
Patients With Mitral Regurgitation
The panels of Figures 3 and 4 suggest that ventricular distension by mitral
regurgitation and aortic pressure head (“mechanical stress”) causes increased
hypoxia-inducible factor (HIF)-1 and potassium inward rectifier (Kir) 6.2 mes-
senger ribonucleic acid (mRNA) expression (gray). Tissue hypoxia, conversely,
increased Kir6.2 protein (red), most probably by inhibition of the proteasomal
Kir6.2 degradation pathway (see text).Kir6.2 protein and mRNA. Precedents of such dissociation ehave previously been noted for other potassium channels
(26) and regulatory proteins (27).
Common and distinct features for the regulation of
cardiac KATP- channel expression. This study has re-
sulted in the analysis of nearly 1,700 relationships among
expression of KATP channels, relevant transcription factors,
pressures, partial blood gas pressures, blood chemistry, and
echocardiographic parameters. For the whole heart, 138 of
the 812 relationships shown in this article are significant
at the 0.05 or 0.01 level. Of 34 significant relationships
in the LV, 12 are also found in the LA. Of 22 significant
relationships in the RV, 10 are also found in the RA. The
HIF-1–Kir6.2/SUR2B mRNA pathway is unique in being
common to all heart chambers. The high percentage of
significant associations common to different heart chambers
supports the notion that the number of type-1 errors were
minimal in pre-planned correlations.
The LA Kir6.2 expression follows a similar pattern as
shown for the LV (see preceding discussion), such as
hypoxic control of Kir6.2 protein expression, the potential
influence of mechanical stress on HIF-1 mRNA, and the
correlation of HIF-1 with Kir6.2 and SUR2B mRNA.
Another common feature is the FOXO1–Kir6.1 mRNA
axis and potential effects on the Kir6.1 protein/mRNA
ratio. The differences relative to the LV are that the LA
Kir6.2 mRNA is negatively linked to the LV systolic and
pulse pressure, and mechanical and transcription factors in
the LA negatively affect Kir6.1 protein expression.
The regulation of left heart Kir6.1 expression appears to
be more complex than for Kir6.2. Transcription factor
HIF-1 is negatively linked to FOXO1 and Kir6.1 mRNA
xpression, possibly resulting in opposite effects on Kir6.1
elative to Kir6.2. As inferred from previous studies (28,29),
he potential implication is a reduced dominant negative
nfluence of Kir6.1, and thus, an enhanced Kir6.2 expression
nd channel pore conductance.
In the right heart, 8 of 15 significant relationships found
etween mRNAs in the RV are also true in the RA. These
oncern the HIF-1–FOXO3–Kir6.2 mRNA axis leading
o a decreased Kir6.2 protein/mRNA ratio, and the associ-
tions among FOXO1–FOXO3, FOXO3–SUR2A/B, and
IF-1–SUR2B mRNAs. Although few correlations
merge with FOXF2 in left heart, RA KIR6.1 protein is
ighly and negatively associated with FOXF2 mRNA.
owever, no mechanical parameters appear to drive RA
OXF2 transcription; thus, the role of FOXF2 in stress-
nduced KATP channel expression remains unknown.
onclusions
his study tests the hypothesis that hypoxic and mechanical
tress determine expression of KATP channel subunits, by
aking advantage of the wide range and large array of clinical
arameters in surgical patients. We encountered unexpected
ndings. Most importantly, LV Kir6.2 protein but not mRNA
xpression depends on tissue hypoxia. Conversely, LV Kir6.2
m
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2
2
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2
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probably through the transcription factor HIF-1. Other
studies could explain the lack of correlation between Kir6.2
mRNA and protein, for example, by a hypoxia-induced in-
creased stability of Kir6.2 protein, or repression of Kir6.2 gene
transcription by excess Kir6.2. Although an HIF-1–Kir6.2
RNA axis is also detectable in the right heart, the right heart
IF-1 mRNA does not respond to mechanical stress, or
lternatively, the mechanical stress is not sufficient to activate
IF-1 mRNA expression.
The clinical implications of these findings are 3-fold. First,
s gauged by the expression of LV Kir6.2 protein, venous
ypoxemia clearly is a sensitive marker of hypoxic cardiac stress
n MR. The measurement of venous PO2 is available to many
clinicians confronted with cardiac pathologies. Second, the
proteasome could represent a pharmacological target for de-
laying the surgical therapy of MR. And third, clinicians will be
increasingly aware of possibly distinct regulations of mRNA
and protein expression in heart disease.
Acknowledgments
The authors thank Dr. Annelise Wohlwend from the
Histology Core Facility of the Geneva Medicine Faculty
(CMU) and Philippe Henchoz of the Pathology and Im-
munology Department, CMU, for help with histology, and
Bernard Cerrutti, CMU, and Thomas Perneger, Geneva
Clinical Research Center, for advice in statistics.
Reprint requests and correspondence: Dr. Alex J. Baertschi,
Centre Médical Universitaire, 1 Rue Michel Servet, 1211 Genève 4,
Switzerland. E-mail: alex.baertschi@unige.ch.
REFERENCES
1. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determi-
nants of mitral, tricuspid, and aortic regurgitation (the Framingham
heart study). Am J Cardiol 1999;83:897–902.
2. Akasaka T, Yoshikawa J, Yoshida K, et al. Age-related valvular
regurgitation: a study by pulsed Doppler echocardiography. Circula-
tion 1987;76:262–5.
3. LaPar DJ, Kron IL. Should all ischemic mitral regurgitation be
repaired? When should we replace? Curr Opin Cardiol 2011;26:
113–7.
4. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve
reconstruction and replacement: comparison of long-term survival and
complications. J Thorac Cardiovasc Surg 2001;122:1107–24.
5. Cleveland JC Jr., Meldrum DR, Cain BS, et al. Oral sulfonylurea
hypoglycemic agents prevent ischemic preconditioning in human
myocardium. Circulation 1997;96:29–32.
6. Speechly-Dick M, Grover GJ, Yellon DM. Does ischemic precondi-
tioning in the human involve protein kinase C and the ATP-
dependent K channel? Studies of contractile function after simulated
ischemia in an atrial in vitro model. Circulation Res 1995;77:1030–5.
7. Bienengraeber M, Olson TM, Selivanov VA, et al. ABCC9 mutations
identified in human dilated cardiomyopathy disrupt catalytic KATP
channel gating. Nat Genet 2004;36:382–77.
8. Olson TM, Alekseev AE, Moreau C, et al. KATP channel mutation
confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin
Pract Cardiovasc Med 2007;4:110–6.
9. Tong X, Porter LM, Liu G, et al. Consequences of cardiac myocyte-
specific ablation of KATP channels in transgenic mice expressing
dominant negative Kir6 subunits. Am J Physiol Heart Circ Physiol
2006;291:H543–51.0. Zingman LV, Hodgson DM, Bast PH, et al. Kir6.2 is required for
adaptation to stress. Proc Natl Acad Sci U S A 2002;99:13278–83.
1. Raeis V, Philip-Couderc P, Roatti A, et al. Central venous hypoxemia
is a determinant of human atrial ATP-sensitive potassium channel
expression: evidence for a novel hypoxia-inducible factor 1alpha-forkhead
box class O signaling pathway. Hypertension 2010;55:1186–92.
2. Philip-Couderc P, Tavares NI, Roatti A, et al. Forkhead transcription
factors coordinate expression of myocardial KATP channel subunits
and energy metabolism. Circ Res 2008;102:e20–35.
3. Pu M, Gao Z, Li J, et al. Development of a new animal model of
chronic mitral regurgitation in rats under transesophageal echocardio-
graphic guidance. J Am Soc Echocardiogr 2005;18:468–74.
4. Barrat-Boyes BG, Wood EH. Cardiac output and related measure-
ments and pressure values in the right heart and associated vessels,
together with an analysis of the hemodynamic response to the
inhalation of high oxygen mixtures in healthy subjects. J Lab Clin Med
1958;51:72–90.
5. Bonow RO, Carabello BA, Chatterjee K, et al. American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. 2008 focused update incorporated into the ACC/AHA
2006 guidelines for the management of patients with valvular heart
disease. J Am Coll Cardiol 2008;52:e1–142.
6. Gottdiener JS, Panza JA, St. John Sutton M, et al. Testing the test: the
reliability of echocardiography in the sequential assessment of valvular
regurgitation. Am Heart J 2002;144:115–21.
7. Klabunde RE. Cardiovascular Physiology Concepts. Philadelphia, PA:
Lippincott Williams & Wilkins, 2005:205–11.
8. Menetrey J, Laumonier T, Garavaglia G, et al. Alpha-smooth muscle
actin and TGF-beta receptor I expression in the healing rabbit medial
collateral and anterior cruciate ligaments. Injury 2011;42:735–41.
9. Hao H, Gabbiani G, Camenzind E, et al. Phenotypic modulation of
intima and media smooth muscle cells in fatal cases of coronary artery
lesion. Arterioscler Thromb Vasc Biol 2006;26:326–32.
0. Gorman RC, Gorman JH, Edmunds HL Jr. Ischemic Mitral Regur-
gitation. In: Cohn LH, Edmunds LH Jr., editors. Cardiac Surgery in
the Adult. New York: McGraw-Hill, 2003:751–69.
1. Tsukamoto O, Minamino T, Kitakaze M. Functional alterations of
cardiac proteasomes under physiological and pathological conditions.
Cardiovasc Res 2010;85:339–46.
2. Tanaka H, Miake J, Notsu T, et al. Proteasomal degradation of Kir6.2
channel protein and its inhibition by a Na channel blocker aprindine.
Biochem Biophys Res Commun 2005;331:1001–6.
3. Yan FF, Lin CW, Cartier EA, et al. Role of ubiquitin-proteasome
degradation pathway in biogenesis efficiency of (beta)-cell ATP-
sensitive potassium channels. Am J Physiol Cell Physiol 2005;289:
C1351–9.
4. Young RM, Wang SJ, Gordan JD, et al. Hypoxia-mediated selective
mRNA translation by an internal ribosome entry site-independent
mechanism. J Biol Chem 2008;283:16309–19.
5. Hansson J, Panchaud A, Favre L, et al. Time-resolved quantitative
proteome analysis of in vivo intestinal development. Mol Cell Pro-
teomics 2010;10:M110.005231.
6. Brundel BJ, Van Gelder IC, Henning RH, et al. Alterations in
potassium channel gene expression in atria of patients with persistent
and paroxysmal atrial fibrillation: differential regulation of protein and
mRNA levels for K channels. J Am Coll Cardiol 2001;37:926–32.
7. Guo Y, Xiao P, Lei S, et al. How is mRNA expression predictive for
protein expression? A correlation study on human circulating mono-
cytes. Acta Biochim Biophys Sin (Shanghai) 2008;40:426–36.
8. Cui Y, Giblin JP, Clapp LH, et al. A mechanism for ATP-sensitive
potassium channel diversity: functional coassembly of two pore-
forming subunits. Proc Natl Acad Sci U S A 2001;98:729–34.
9. Zerangue N, Schwappach B, Jan YN, Jan LY. A new ER trafficking
signal regulates the subunit stoichiometry of plasma membrane
K(ATP) channels. Neuron 1999;22:537–48.
Key Words: ischemia y Kir6.2 expression y mechanical stress y mitral
regurgitation y transcription.
APPENDIX
For supplemental tables and figures,
please see the online version of this article.
